Synthesis, characterization and in vitro cytotoxicity of platinum(II) complexes of selenones [Pt(selenone)2Cl2]

Unknown

(2018)   Chemistry-An Asian Journal

Platinum-based drugs: past, present and future

(2016) Shahana Dilruba et al.   CANCER CHEMOTHERAPY AND PHARMACOLOGY

The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs

(2016) Timothy C. Johnstone et al.   CHEMICAL REVIEWS

Cisplatin binding to proteins: A structural perspective

(2016) Luigi Messori et al.   COORDINATION CHEMISTRY REVIEWS

Synthesis and biological evaluation of water-solubletrans-[bicyclo[2.2.2]octane-7R,8R-diamine]platinum(II) complexes with linear or branched alkoxyacetates as leaving groups

(2016) Fengfan Liu et al.   JOURNAL OF COORDINATION CHEMISTRY

Synthesis, cytotoxicity, and interaction with DNA of platinum(II) complexes of (1R,2R)-N1-2-amyl-1,2-diaminocyclohexane

(2016) Aifeng Lyu et al.   JOURNAL OF COORDINATION CHEMISTRY

Synthesis, characterization, DNA binding studies andin vitrocytotoxicity of platinum(II)-dihalogenido complexes containing bidentate chelatingN-donor ligands

(2016) Radka Křikavová et al.   JOURNAL OF COORDINATION CHEMISTRY

Synthesis, characterization, and anticancer activities of lipophilic pyridinecarboxaldimine platinum(II) complexes

(2016) Brittany A. Miles et al.   POLYHEDRON

Unknown

(2016)   CHEMISTRY & BIODIVERSITY

Synthesis, structure, andin vitrocytotoxicity of organoplatinum(II) complexes containing aryl olefins and quinolines

(2015) Tran Thi Da et al.   JOURNAL OF COORDINATION CHEMISTRY

Acetate platinum(II) compound with 5,7-ditertbutyl-1,2,4-triazolo[1,5-a]pyrimidine that overcomes cisplatin resistance: structural characterization,in vitrocytotoxicity, and kinetic studies

(2015) Kamil Hoffmann et al.   JOURNAL OF COORDINATION CHEMISTRY

Tetrakis(thione)platinum(II) complexes: synthesis, spectroscopic characterization, crystal structures, andin vitrocytotoxicity

(2015) A. Zainelabdeen A. Mustafa et al.   JOURNAL OF COORDINATION CHEMISTRY

Synthesis and anticancer activity of diam(m)ine platinum(II) complexes with 3-oxo-cyclobutane-1,1-dicarboxylate as the leaving group

(2015) Wen Tian et al.   RESEARCH ON CHEMICAL INTERMEDIATES

Redox-Active Selenium Compounds—From Toxicity and Cell Death to Cancer Treatment

(2015) Sougat Misra et al.   Nutrients

Cisplatin in cancer therapy: Molecular mechanisms of action

(2014) Shaloam Dasari et al.   EUROPEAN JOURNAL OF PHARMACOLOGY

Tetrakis(1-3-diazinane-2-thione)platinum(II) chloride monohydrate complex: Synthesis, spectroscopic characterization, crystal structure and in vitro cytotoxic activity against A549, MCF7, HCT15 and HeLa human cancer lines

(2014) A. Zainelabdeen A. Mustafa et al.   INORGANIC CHEMISTRY COMMUNICATIONS

Platinum drugs and neurotoxicity: effects on intracellular calcium homeostasis

(2013) Valeria Maria Piccolini et al.   CELL BIOLOGY AND TOXICOLOGY

Palladium(II) and platinum(II) bis(thiosemicarbazone) complexes of the 2,6-diacetylpyridine series with high cytotoxic activity in cisplatin resistant A2780cisR tumor cells and reduced toxicity

(2013) Ana I. Matesanz et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Targeting and delivery of platinum-based anticancer drugs

(2012) Xiaoyong Wang et al.   CHEMICAL SOCIETY REVIEWS

Cytotoxic platinum(ii) intercalators that incorporate 1R,2R-diaminocyclopentane

(2012) K. Benjamin Garbutcheon-Singh et al.   DALTON TRANSACTIONS

DNA binding studies of a series of cis-[Pt(Am)2X2] complexes (Am=inert amine, X=labile carboxylato ligand)

(2012) Esther Escribano et al.   INORGANICA CHIMICA ACTA

Antitumor carboplatin is more toxic in tumor cells when photoactivated: enhanced DNA binding

(2012) Jarmila Mlcouskova et al.   JOURNAL OF BIOLOGICAL INORGANIC CHEMISTRY

Antitumor activities and interaction with DNA of oxaliplatin-type platinum complexes with linear or branched alkoxyacetates as leaving groups

(2011) Runting Yin et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Unique platinum–DNA interactions may lead to more effective platinum-based antitumor drugs

(2011) Seiji Komeda   Metallomics

Molecular mechanisms of cisplatin resistance

(2011) L Galluzzi et al.   ONCOGENE

Cisplatin as an Anti-Tumor Drug: Cellular Mechanisms of Activity, Drug Resistance and Induced Side Effects

(2011) Ana-Maria Florea et al.   Cancers

The status of platinum anticancer drugs in the clinic and in clinical trials

(2010) Nial J. Wheate et al.   DALTON TRANSACTIONS

A consistent and accurate ab initio parametrization of density functional dispersion correction (DFT-D) for the 94 elements H-Pu

(2010) Stefan Grimme et al.   JOURNAL OF CHEMICAL PHYSICS

New platinum–oxicam complexes as anti-cancer drugs. Synthesis, characterization, release studies from smart hydrogels, evaluation of reactivity with selected proteins and cytotoxic activity in vitro

(2010) Gabriella Tamasi et al.   JOURNAL OF INORGANIC BIOCHEMISTRY

Non-traditional platinum compounds for improved accumulation, oral bioavailability, and tumor targeting

(2009) Katherine S. Lovejoy et al.   DALTON TRANSACTIONS

Platinum Anticancer Coordination Compounds: Study of DNA Binding Inspires New Drug Design

(2009) Jan Reedijk   EUROPEAN JOURNAL OF INORGANIC CHEMISTRY

Trans geometry in platinum antitumor complexes

(2007) Urszula Kalinowska-Lis et al.   COORDINATION CHEMISTRY REVIEWS